168 related articles for article (PubMed ID: 29600661)
21. Efficacy and Safety of GuiZhi-ShaoYao-ZhiMu Decoction for Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Daily JW; Zhang T; Cao S; Park S
J Altern Complement Med; 2017 Oct; 23(10):756-770. PubMed ID: 28609129
[TBL] [Abstract][Full Text] [Related]
22. [Predictive model for hygroscopicity of contents in Guizhi Fuling Capsules].
Wang Q; Xu B; Wang F; Xu FF; Zhang X; Zhang YC; DU H; Xia CY; Bao LW; Wang ZZ; Qiao YJ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(2):242-249. PubMed ID: 32237305
[TBL] [Abstract][Full Text] [Related]
23. [Research on immune-modulation effects and its mechanisms of Guizhi Fuling capsule and its active ingredient combination].
Jiang YP; Wu X; Li N; Cao L; Ding G; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3068-71. PubMed ID: 26677713
[TBL] [Abstract][Full Text] [Related]
24. [Main progress on studies of pharmacological activities and clinical applications of Guizhi Fuling capsule].
Su ZZ; Li N; Cao L; Wang TJ; Zhang CF; Ding G; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):989-92. PubMed ID: 26226732
[TBL] [Abstract][Full Text] [Related]
25. [Discrete element simulation study of mixing process of Guizhi Fuling Capsules: parameter calibration].
Li HZ; Tang XF; Lin Y; Xu FF; Zhang X; Ye HQ; Xiao W; Wang ZZ; Xu B
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4007-4014. PubMed ID: 37802768
[TBL] [Abstract][Full Text] [Related]
26. Potential Mechanisms of Guizhi Fuling Wan in Treating Endometriosis: An Analysis Based on TCMSP and DisGeNET Databases.
Yee JL; Huang CY; Yu YC; Huang SJ
J Ethnopharmacol; 2024 Jul; 329():118190. PubMed ID: 38614264
[TBL] [Abstract][Full Text] [Related]
27. [Simultaneous determination of six triterpenoid acids from Guizhi Fuling capsules by UPLC-MS/MS].
Ma Y; Li JC; Huang WZ; Wang ZZ; Xiao W; Song YL; Zhang YW
Zhongguo Zhong Yao Za Zhi; 2017 Sep; 42(17):3368-3373. PubMed ID: 29192448
[TBL] [Abstract][Full Text] [Related]
28. [Quality analysis of Guizhi Fuling capsule before and after application of in-process quality control in pharmaceutical production].
Li JC; Wang JL; Wu JL; Huang WZ; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1017-22. PubMed ID: 26226737
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics Study of Guizhi Fuling Capsules in Rats With Cold Coagulation Dysmenorrhea.
Zhang Y; Su N; Liu W; Wang Q; Sun J; Peng Y
Front Pharmacol; 2021; 12():764904. PubMed ID: 34776980
[TBL] [Abstract][Full Text] [Related]
30. [Mechanism Study on Danggui Shaoyao San and Guizhi Fuling Wan For Treating Primary Dysmenorrheal Based on Biological Network].
Wang YL; Ru SY; Fang Q; Li GQ; Pan YF; Yao Y; Xu F
Zhong Yao Cai; 2015 Nov; 38(11):2348-52. PubMed ID: 27356390
[TBL] [Abstract][Full Text] [Related]
31. Post-marketing safety monitoring of shenqifuzheng injection: a solution made of dangshen (Radix Codonopsis) and huangqi (Radix Astragali Mongolici).
Ai Q; Zhang W; Xie Y; Huang W; Liang H; Cao H
J Tradit Chin Med; 2014 Aug; 34(4):498-503. PubMed ID: 25185371
[TBL] [Abstract][Full Text] [Related]
32. Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine: a systematic review of randomized clinical trials.
Luo H; Li Q; Flower A; Lewith G; Liu J
J Ethnopharmacol; 2012 Apr; 140(3):555-67. PubMed ID: 22343092
[TBL] [Abstract][Full Text] [Related]
33. [Systematic review of medication safety of Xiyanping injection in conformity with indications of package inserts].
Chen YY; Xie YM; Liao X; Chen HY
Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(18):3463-3472. PubMed ID: 28925133
[TBL] [Abstract][Full Text] [Related]
34. Safety of the Xuesaitong injection in China: results from a large-scale multicentre post-marketing surveillance study in a real-world setting.
He Y; Gao XM; Li L; Liu XG; Liu W; Hong XJ; Huang BH; Yang HL; Xue MH; Wu XJ; Liu JF
Curr Med Res Opin; 2020 Dec; 36(12):1947-1953. PubMed ID: 33016133
[TBL] [Abstract][Full Text] [Related]
35. [Differential analysis of different study types in clinical safety evaluation of Xuebijing Injection].
Li Q; Jin XY; Zhou X; Pang WT; Wang KY; Li N; Zheng WK
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):712-721. PubMed ID: 33645039
[TBL] [Abstract][Full Text] [Related]
36. [Effects of guizhi fuling capsule on sex hormone levels and breast issue morphology of mammary gland hyperplasia model rats].
Chang XJ; Zhou J; Zhang S; Chen J; Chen CM; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(21):4139-42. PubMed ID: 25775782
[TBL] [Abstract][Full Text] [Related]
37. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
Ai QH; Li YY; Xie YM
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
[TBL] [Abstract][Full Text] [Related]
38. [Meta-analysis on incidence of adverse drug reaction induced by Shuanghuanglian injection].
Tang W; Shi QP; Ma T; Jiang XD; Liu SX; Wang YX
Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2732-2742. PubMed ID: 28905614
[TBL] [Abstract][Full Text] [Related]
39. [Rapid identification of six chemical constituents in Guizhi Fuling capsule by DART-Q-TOF-MS].
Wei Z; Xue W; Yan-jing-ping ; Li YJ; Bi YA; Wang ZZ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(21):4118-22. PubMed ID: 25775778
[TBL] [Abstract][Full Text] [Related]
40. [Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine (draft version for comments)].
Xie YM; Liao X; Zhao YB; Li MQ; Zhang YL; Ma R; Xian SX; Liu J; Li SY; Wen ZH; Yang ZQ; Zou JD; Sun HS; He Y; Li XL; Jiang JJ; Wang ZF; Li YY; Wang LX; Chang YP; Yang W; Zhang W
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2919-24. PubMed ID: 24471304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
